Moderna Stock News & Updates
[WKN: A2N9D9 | Symbol: MRNA]
Geopolitics Meets AI Boom – Bitcoin Recovers Above $72,000 – Crypto Stocks Lead Price Lists – Moderna Resolves Billion-Dollar Risk - CoreWeave's Strategic Perplexity Partnership – Discount Retailer Ross Stores with Excellent Figures - Telus Invests in AST SpaceMobile
USA & MACRO-ENVIRONMENT Wall Street navigates through a challenging market environment this Wednesday,...
Tracking the Pivotal Point of Moderna (MRNA): Shift Away from COVID Focus After Breakthrough in Personalized Cancer Immunotherapy!
Moderna is a pioneer in mRNA technology and gained worldwide recognition through the success of its COVID-19...
Moderna: Revenue Surprise and Cancer Pipeline – The Starting Signal for Re-evaluation has Been Given!
Moderna defies the swan song of the post-Covid era and significantly exceeds Wall Street expectations...
Focus on Iran Negotiations – Inflation More Moderate Than Expected – Palantir with DISA Authorization and Airbus Deal – OpenClaw Founder Joins OpenAI – Coinbase with Strong Trading Comeback – Rivian with Optimistic Sales Forecast – Albemarle Pulls Emergency Brake in Australia – Moderna Resists FDA Setback – Growth Pains at Nebius
On Friday, February 13, 2026, the US markets exhibited mixed results, continuing their recent difficult...
More Than Just Covid: How Moderna is Planning to Defeat Cancer with AI and mRNA
Despite current operational losses, the company secures its future with a massive cash cushion of...
Moderna: The Long Wait for the Cancer Breakthrough Could Soon be Over
It is January 2026, and a glance at Moderna's stock price shows that the "Long Covid" effect on the market...
Why I Believe that Investing in Moderna at this Point Represents a Promising Opportunity!
The stock of Moderna is currently in a multi-year downtrend and could be forming a bottom, after the...
Moderna: Seasonally Strong thanks to Vaccine Demand in November
Moderna is a US biotechnology company headquartered in Cambridge, Massachusetts, that specializes in...
Moderna: Partnership With IBM to Accelerate mRNA Development
Moderna is a US-based biotechnology company headquartered in Cambridge, Massachusetts, that specializes...
Moderna: The CEO Buys Shares Worth $5 Million. Ten new Products are Expected to be Launched by 2027. Rebound Opportunity!
Is it possible that things are not so bad behind the scenes at Moderna (MRNA)? The share price with...
Moderna: More than just COVID-19
Moderna has made a name for itself with its mRNA vaccine against COVID-19, but the company is already...